Works matching AU Rosing, Hilde

Results: 107

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Published in:

Oncology & Therapy, 2025, v. 13, n. 2, p. 465, doi. 10.1007/s40487-025-00340-8

By:

Voogd, Daphne W. M.;
Lucassen, Merel J. J.;
van der Noll, Ruud;
Zielhuis, Sybrand W. J.;
Boss, David;
Beijnen, Jos H.;
Rosing, Hilde;
Tibben, Matthijs;
Huitema, Alwin D. R.;
Schellens, Jan H. M.;
Steeghs, Neeltje

Publication type:

Article

Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 8, p. 1075, doi. 10.1007/s00228-020-02888-y

By:

Roosendaal, Jeroen;
Groenland, Stefanie L.;
Rosing, Hilde;
Lucas, Luc;
Venekamp, Nikkie;
Nuijen, Bastiaan;
Huitema, Alwin D. R.;
Beijnen, Jos H.;
Steeghs, Neeltje

Publication type:

Article

The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 737, doi. 10.1007/s00228-018-2426-4

By:

Jacobs, Bart A. W.;
Snoeren, Nikol;
Samim, Morsal;
Rosing, Hilde;
de Vries, Niels;
Deenen, Maarten J.;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Koopman, Miriam;
van Hillegersberg, Richard

Publication type:

Article

Toxicological analysis of azide and cyanide for azide intoxications using gas chromatography.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 534, doi. 10.1111/bcpt.13523

By:

Bruin, Maaike A. C.;
Dekker, Douwe;
Venekamp, Nikkie;
Tibben, Matthijs;
Rosing, Hilde;
de Lange, Dylan W.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 2, p. 155, doi. 10.1002/jcph.2362

By:

van der Heijden, Lisa T.;
Ribbers, Claire A.;
Vermunt, Marit A.C.;
Pluim, Dick;
Acda, Manon;
Tibben, Matthijs;
Rosing, Hilde;
Douma, Joeri A.J.;
Naipal, Kishan;
Bergman, Andre M.;
Beijnen, Jos H.;
Huitema, Alwin D.R.;
Opdam, Frans L.

Publication type:

Article

Simultaneous quantification of 2′,2′-difluorodeoxycytidine and 2′,2′-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2009, v. 23, n. 19, p. 3040, doi. 10.1002/rcm.4212

By:

Jansen, Robert S.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometry

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2009, v. 23, n. 6, p. 763, doi. 10.1002/rcm.3938

By:

Damen, Carola W. N.;
Israëls, Trijn;
Caron, Huib N.;
Schellens, Jan H.M.;
Rosing, Hilde;
Beijnen, Jos H.

Publication type:

Article

Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin® given intravesically

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2008, v. 22, n. 4, p. 462, doi. 10.1002/rcm.3387

By:

Vainchtein, Liia D.;
Rosing, Hilde;
Mirejovsky, Dorla;
Huynh, Van;
Lenaz, Luigi;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Development and validation of an assay for the quantitative determination of cladribine nucleotides in MDCKII cells and culture medium using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 24, p. 4049, doi. 10.1002/rcm.3318

By:

Jansen, Robert S.;
Rosing, Hilde;
de Wolf, Cocky J. F.;
Beijnen, Jos H.

Publication type:

Article

Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 15, p. 2505, doi. 10.1002/rcm.3119

By:

ter Heine, Rob;
Alderden-Los, Carolien G.;
Rosing, Hilde;
Hillebrand, Michel J. X.;
van Gorp, Eric C. M.;
Huitema, Alwin D. R.;
Beijnen, Jos H.

Publication type:

Article

Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 14, p. 2312, doi. 10.1002/rcm.3096

By:

Vainchtein, Liia D.;
Rosing, Hilde;
Thijssen, Bas;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 9, p. 1521, doi. 10.1002/rcm.2985

By:

Brouwers, Elke E. M.;
Tibben, Matthijs M.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2006, v. 20, n. 22, p. 3330, doi. 10.1002/rcm.2737

By:

Frankfort, Suzanne V.;
Ouwehand, Mariët;
van Maanen, Maria J.;
Rosing, Hilde;
Tulner, Linda R.;
Beijnen, Jos H.

Publication type:

Article

Quantitative analysis of the farnesyl transferase inhibitor lonafarnib (Sarasar™, SCH66336) in human plasma using high-performance liquid chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2005, v. 19, n. 15, p. 2187, doi. 10.1002/rcm.2046

By:

Appels, Natalie M. G. M.;
van Maanen, Maria J.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2005, v. 19, n. 3, p. 401, doi. 10.1002/rcm.1790

By:

Stokvis, Ellen;
Rosing, Hilde;
Beijnen, Jos H.

Publication type:

Article

Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 23, p. 2839, doi. 10.1002/rcm.1699

By:

Beumer, Jan Hendrik;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Nan-Offeringa, Lianda G. A. H.;
Foley, Karen;
Yule, S. Murray;
Heck, Albert J. R.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 13, p. 1465, doi. 10.1002/rcm.1493

By:

Stokvis, Ellen;
Nan-Offeringa, Lianda G. A. H.;
Ouwehand, Mariët;
Tibben, Matthijs M.;
Rosing, Hilde;
Schnaars, Yvonne;
Grigat, Martina;
Romeis, Peter;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Exposure‐Response Assessment of Enzalutamide and Its Major Metabolites in a Real‐World Cohort of Patients with Metastatic Castration‐Resistant Prostate Cancer.

Published in:

Pharmacotherapy, 2019, v. 39, n. 12, p. 1137, doi. 10.1002/phar.2339

By:

Nuland, Merel;
Bergman, Andries M.;
Rosing, Hilde;
Vries, Niels;
Huitema, Alwin D.R.;
Beijnen, Jos H.

Publication type:

Article

Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 5, p. 1211, doi. 10.1093/jac/dks011

By:

Kromdijk, Wiete;
Mulder, Jan W.;
Rosing, Hilde;
Smit, Patrick M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Facile Small Scale Synthesis of Nucleoside 5'-Phosphate Mixtures.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2010, v. 29, n. 1, p. 14, doi. 10.1080/15257770903451546

By:

Jansen, RobertS.;
Rosing, Hilde;
Schellens, JanHM;
Beijnen, JosH.

Publication type:

Article

Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 12, p. 940, doi. 10.1002/psp4.12474

By:

Jacobs, Bart A.W.;
Deenen, Maarten J.;
Joerger, Markus;
Rosing, Hilde;
Vries, Niels;
Meulendijks, Didier;
Cats, Annemieke;
Beijnen, Jos H.;
Schellens, Jan H.M.;
Huitema, Alwin D.R.

Publication type:

Article

A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 607, doi. 10.1002/cpdd.880

By:

Weger, Vincent A.;
Vermunt, Marit A.C.;
Stuurman, Frederik E.;
Burylo, Artur M.;
Damoiseaux, David;
Hendrikx, Jeroen J.M.A.;
Sawicki, Emilia;
Moes, Johannes J.;
Huitema, Alwin D.R.;
Nuijen, Bastiaan;
Rosing, Hilde;
Mergui‐Roelvink, Marja;
Beijnen, Jos H.;
Marchetti, Serena

Publication type:

Article

Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 552, doi. 10.1002/cpdd.840

By:

Roosendaal, Jeroen;
Rosing, Hilde;
Beijnen, Jos H.

Publication type:

Article

A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 899, doi. 10.1177/10781552221089243

By:

Nijstad, A Laura;
de Vos-Kerkhof, Evelien;
Enters-Weijnen, Catherine F;
van de Wetering, Marianne D;
Tissing, Wim J E;
Hanff, Lidwien M;
Lange, Rogier;
Tibben, Matthijs M;
Rosing, Hilde;
Lalmohamed, Arief;
Zwaan, C Michel;
Huitema, Alwin D R

Publication type:

Article

Urinary excretion of paclitaxel and metabolites in a large series of study.

Published in:

Journal of Oncology Pharmacy Practice, 1998, v. 4, n. 3, p. 159, doi. 10.1177/107815529800400304

By:

Panday, Vinodh R. Nannan;
Rosing, Hilde;
Huizing, Manon T.;
Koopman, Francesca J.;
van Warmerdam, Laurence J.C.;
Huinik, Wim W. ten Bokkel;
Beijnen, Jos H.

Publication type:

Article

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism.

Published in:

2007

By:

van Herwaarden, Antonius E.;
Wagenaar, Els;
van der Kruijssen, Cornelia M. M.;
van Waterschoot, Robert A. B.;
Smit, Johan W.;
Ji-Ying Song;
van der Valk, Martin A.;
van Tellingen, Olaf;
van der Hoorn, José W. A.;
Rosing, Hilde;
Beijnen, Jos H.;
Schinkel, Alfred H.;
Song, Ji-Ying;
van der Hoorn, José W A

Publication type:

journal article

Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment.

Published in:

Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 1, p. 79, doi. 10.1007/s00280-024-04662-8

By:

Loos, Nancy H.C.;
Bui, Viët;
de Jong, Daniëlle H.;
Lebre, Maria C.;
Rosing, Hilde;
Beijnen, Jos H.;
Schinkel, Alfred H.

Publication type:

Article

Assay performance and stability of uracil and dihydrouracil in clinical practice.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 3, p. 257, doi. 10.1007/s00280-023-04518-7

By:

Knikman, Jonathan E.;
Rosing, Hilde;
Guchelaar, Henk-Jan;
Cats, Annemieke;
Beijnen, Jos H.

Publication type:

Article

Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 785, doi. 10.1007/s00280-022-04433-3

By:

Vermunt, Marit A. C.;
van Nuland, Merel;
van der Heijden, Lisa T.;
Rosing, Hilde;
Beijnen, Jos. H.;
Bergman, Andries M.

Publication type:

Article

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.

Published in:

2020

By:

Huijberts, Sanne C. F. A.;
van Geel, Robin M. J. M.;
van Brummelen, Emilie M. J.;
Opdam, Frans L.;
Marchetti, Serena;
Steeghs, Neeltje;
Pulleman, Saskia;
Thijssen, Bas;
Rosing, Hilde;
Monkhorst, Kim;
Huitema, Alwin D. R.;
Beijnen, Jos H.;
Bernards, René;
Schellens, Jan H. M.

Publication type:

journal article

A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine.

Published in:

2016

By:

Jacobs, Bart;
Meulenaar, Jelte;
Rosing, Hilde;
Pluim, Dick;
Tibben, Matthijs;
Vries, Niels;
Nuijen, Bastiaan;
Huitema, Alwin;
Beijnen, Jos;
Schellens, Jan;
Marchetti, Serena;
Jacobs, Bart A W;
Tibben, Matthijs M;
de Vries, Niels;
Huitema, Alwin D R;
Beijnen, Jos H;
Schellens, Jan H M

Publication type:

journal article

Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Published in:

2013

By:

Milojkovic Kerklaan, Bojana;
Diéras, Veronique;
Tourneau, Christophe;
Mergui-Roelvink, Marja;
Huitema, Alwin;
Rosing, Hilde;
Beijnen, Jos;
Marreaud, Sandrine;
Govaerts, Anne-Sophie;
Piccart-Gebhart, Martine;
Schellens, Jan;
Awada, Ahmad

Publication type:

Correction Notice

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 53, doi. 10.1007/s00280-012-1972-1

By:

Kerklaan, Bojana;
Diéras, Veronique;
Tourneau, Christophe;
Mergui-Roelvink, Marja;
Huitema, Alwin;
Rosing, Hilde;
Beijnen, Jos;
Marreaud, Sandrine;
Govaerts, Anne-Sophie;
Piccart-Gebhart, Martine;
Schellens, Jan;
Awada, Ahmad

Publication type:

Article

Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 6, p. 1457, doi. 10.1007/s00280-012-1850-x

By:

Jansen, Robert;
Rosing, Hilde;
Wijermans, Pierre;
Keizer, Ron;
Schellens, Jan;
Beijnen, Jos

Publication type:

Article

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 6, p. 825, doi. 10.1007/s00280-006-0342-2

By:

Beumer, Jan H.;
Rademaker-Lakhai, Jeany M.;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Bosch, Tessa M.;
Lopez-Lazaro, Luis;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 514, doi. 10.1007/s00280-002-0516-5

By:

Schoemaker, Nadja E.;
Mathät, Ron A.;
Schäffski, Patrick;
Rosing, Hilde;
Schellens, Jan H.;
Beijnen, Jos H.

Publication type:

Article

Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 473, doi. 10.1007/s00280-002-0515-6

By:

Crul, Mirjam;
Beerepoot, Laurens V.;
Stokvis, Ellen;
Vermaat, Johannes S.;
Rosing, Hilde;
Beijnen, Jos H.;
Voest, Emile E.;
Schellens, Jan H.

Publication type:

Article

Urinary and fecal excretion of topotecan in patients with malignant solid tumours.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 59, doi. 10.1007/s00280-002-0454-2

By:

Herben, Virginie M. M.;
Schoemaker, Nadja E.;
Rosing, Hilde;
van Zomeren, Desiree M.;
ten Bokkel Huinink, Wim W.;
Dubbelman, Ria;
Hearn, Solange;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Population pharmacokinetics of the novel anticancer agent KRN7000.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 4, p. 287, doi. 10.1007/s00280-001-0413-3

By:

Crul, Mirjam;
Mathôt, Ron A. A.;
Giaccone, Giuseppe;
Punt, Cornelis J. A.;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Ando, Yoshitaka;
Nishi, Nobosuke;
Tanaka, Hideji;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency.

Published in:

International Journal of Cancer, 2018, v. 142, n. 2, p. 424, doi. 10.1002/ijc.31065

By:

Henricks, Linda M.;
Siemerink, Ester J. M.;
Rosing, Hilde;
Meijer, Judith;
Goorden, Susan M. I.;
Polstra, Abeltje M.;
Zoetekouw, Lida;
Cats, Annemieke;
Schellens, Jan H. M.;
van Kuilenburg, André B. P.

Publication type:

Article

Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.

Published in:

International Journal of Cancer, 2016, v. 138, n. 3, p. 758, doi. 10.1002/ijc.29812

By:

Hendrikx, Jeroen J.M.A.;
Lagas, Jurjen S.;
Song, Ji‐Ying;
Rosing, Hilde;
Schellens, Jan H.M.;
Beijnen, Jos H.;
Rottenberg, Sven;
Schinkel, Alfred H.

Publication type:

Article

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel.

Published in:

International Journal of Cancer, 2015, v. 136, n. 1, p. 225, doi. 10.1002/ijc.28970

By:

Iusuf, Dilek;
Hendrikx, Jeroen J.M.A.;
van Esch, Anita;
van de Steeg, Evita;
Wagenaar, Els;
Rosing, Hilde;
Beijnen, Jos H.;
Schinkel, Alfred H.

Publication type:

Article

P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.

Published in:

International Journal of Cancer, 2013, v. 132, n. 10, p. 2439, doi. 10.1002/ijc.27912

By:

Hendrikx, Jeroen J.M.A.;
Lagas, Jurjen S.;
Rosing, Hilde;
Schellens, Jan H.M.;
Beijnen, Jos H.;
Schinkel, Alfred H.

Publication type:

Article

Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.

Published in:

International Journal of Cancer, 2010, v. 127, n. 12, p. 2959, doi. 10.1002/ijc.25279

By:

van Waterschoot, Robert A.B.;
Lagas, Jurjen S.;
Wagenaar, Els;
Rosing, Hilde;
Beijnen, Jos H.;
Schinkel, Alfred H.

Publication type:

Article

The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma Patients.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 10, p. 1307, doi. 10.1002/jcph.728

By:

Nijenhuis, Cynthia M.;
Huitema, Alwin D.R.;
Marchetti, Serena;
Blank, Christian;
Haanen, John B.A.G.;
Thienen, Johannes V.;
Rosing, Hilde;
Schellens, Jan H.M.;
Beijnen, Jos H.

Publication type:

Article

Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk.

Published in:

Molecular & Cellular Biology, 2007, v. 27, n. 4, p. 5, doi. 10.1128/MCB.01621-06

By:

Van Herwaarden, Antonius E.;
Wagenaar, Els;
Merino, Gracia;
Jonker, Johan W.;
Rosing, Hilde;
Beijnen, Jos H.;
Schinkel, Alfred H.

Publication type:

Article

Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.

Published in:

Drugs in R&D, 2021, v. 21, n. 1, p. 103, doi. 10.1007/s40268-020-00336-x

By:

Vermunt, Marit A. C.;
de Weger, Vincent A.;
Janssen, Julie M.;
Lopez-Yurda, Marta I.;
Keessen, Marianne;
Thijssen, Bas;
Rosing, Hilde;
Huitema, Alwin D. R.;
Beijnen, Jos H.;
Marchetti, Serena

Publication type:

Article

Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology.

Published in:

Drugs in R&D, 2020, v. 20, n. 2, p. 147, doi. 10.1007/s40268-020-00304-5

By:

Roosendaal, Jeroen;
Rosing, Hilde;
Beijnen, Jos H.

Publication type:

Article

Pharmacokinetics and Excretion of C-Bendamustine in Patients with Relapsed or Refractory Malignancy.

Published in:

Drugs in R&D, 2013, v. 13, n. 1, p. 17, doi. 10.1007/s40268-012-0001-5

By:

Dubbelman, Anne-Charlotte;
Rosing, Hilde;
Darwish, Mona;
D'Andrea, Denise;
Bond, Mary;
Hellriegel, Edward;
Robertson, Philmore;
Beijnen, Jos;
Schellens, Jan

Publication type:

Article

Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma.

Published in:

Cancers, 2021, v. 13, n. 22, p. 5780, doi. 10.3390/cancers13225780

By:

Molenaar-Kuijsten, Laura;
van Meekeren, Milan;
Verheijen, Remy B.;
Bovée, Judith V. M. G.;
Fiocco, Marta;
Thijssen, Bas;
Rosing, Hilde;
Huitema, Alwin D. R.;
Miah, Aisha B.;
Gelderblom, Hans;
Haas, Rick L. M.;
Steeghs, Neeltje

Publication type:

Article